LFMD250117P12000
- 5.19
- 0.000.00%
LifeMD Newsroom
LifeMD Is Maintained at Overweight by Keybanc
KeyBanc Maintains LifeMD(LFMD.US) With Buy Rating, Cuts Target Price to $7
KeyBanc Cuts Price Target on LifeMD to $7.50 From $10, Keeps Overweight Rating
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND For GLP-1 Users & Those Looking for Help to Keep Weight Off
Insider Sale: Chief Executive Officer of $LFMD (LFMD) Sells 25,000 Shares
LifeMD, Inc. 8.875% CUM PFD A Goes Ex Dividend Tomorrow
LifeMD Sets New CEO Compensation Strategy
Analysts Expect Breakeven For LifeMD, Inc. (NASDAQ:LFMD) Before Long
LifeMD, Inc. Announces Cash Dividend for Series A Preferred Stock Holders
Press Release: LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD) and Dexcom (DXCM)
Lake Street Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
Mizuho Securities Maintains LifeMD(LFMD.US) With Hold Rating
Mizuho Securities Sticks to Its Hold Rating for LifeMD (LFMD)
Lake Street Initiates Coverage On LifeMD With Buy Rating, Announces Price Target of $12
Lake Street Starts Virtual Primary Care Provider LifeMD With a Buy
Lake Street Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $12
This Insider Has Just Sold Shares In LifeMD
Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even With Weight Loss Medications
LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution